High-Risk Device Scrutiny On Agenda Of 2016’s First EU Medtech Regulation trilogue
This article was originally published in Clinica
Executive Summary
The scrutiny of high-risk devices, one of the areas within the new EU medtech regulations on which the authorities have found most difficulty to agree, will be up for debate on Feb 4.